Get the Stockscreener App
12.34
0.08%
+0.010
Pre-market:
12.30
-0.04
-0.32%
Hims & Hers Health Inc stock is currently priced at $12.34, with a 24-hour trading volume of 2.98M.
It has seen a +0.08% increased in the last 24 hours and a -24.43% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $12.27 pivot point. If it approaches the $12.62 resistance level, significant changes may occur.
Previous Close:
$12.33
Open:
$12.46
24h Volume:
2.98M
Market Cap:
$2.64B
Revenue:
$872.00M
Net Income/Loss:
$-23.55M
P/E Ratio:
-72.59
EPS:
-0.17
Net Cash Flow:
$46.99M
1W Performance:
-0.56%
1M Performance:
-24.43%
6M Performance:
+97.12%
1Y Performance:
+4.49%
1D Range:
$12.14
$12.60
52W Range:
$5.65
$17.16
Hims & Hers Health Inc Stock (HIMS) Company Profile
Name
Hims & Hers Health Inc
Sector
Industry
Phone
800-368-0038
Address
340 Bryant Street, 3rd Floor, San Francisco
Hims & Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims & Hers Health Inc Stock (HIMS) Latest News
Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: What You Should Know
Zacks Investment Research
Why Hims & Hers Stock Was Down This Week
The Motley Fool
Zacks Investment Ideas feature highlights: Hims & Hers Health, Coinbase Global
Zacks Investment Research
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights
Zacks Investment Research
Investing in Growth: 2 Top-Ranked Stocks with Huge Potential
Zacks Investment Research
Hims & Hers Health, Inc. (HIMS) Rises But Trails Market: What Investors Should Know
Zacks Investment Research
Hims & Hers Health Inc Stock (HIMS) Financials Data
Hims & Hers Health Inc (HIMS) Revenue 2024
HIMS reported a revenue (TTM) of $872.00 million for the quarter ending December 31, 2023, a +65.49% rise year-over-year.
Hims & Hers Health Inc (HIMS) Net Income 2024
HIMS net income (TTM) was -$23.55 million for the quarter ending December 31, 2023, a +64.15% increase year-over-year.
Hims & Hers Health Inc (HIMS) Cash Flow 2024
HIMS recorded a free cash flow (TTM) of $46.99 million for the quarter ending December 31, 2023, a +239.12% increase year-over-year.
Hims & Hers Health Inc (HIMS) Earnings per Share 2024
HIMS earnings per share (TTM) was -$0.11 for the quarter ending December 31, 2023, a +65.62% growth year-over-year.
About Hims & Hers Health Inc
Hims, Inc. manufactures men's wellness products. It offers products, including hair loss prevention medicines, sexual wellness products, skincare products, and oral care products. The company also provides sweaters, jackets, corduroy, sport coats, wool overcoat, leather boots, flannel, shirts, caps, and candles. It sells its products online. The company was incorporated in 2013 and is based in San Francisco, California.
0.01%
0.09%
Cap:
|
Volume (24h):